INCR DEADLINE ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Syneos Health, Inc. (formerly INC Research Holdings, Inc.) and a Lead Plaintiff Deadline of January 30, 2018

NEW YORK, NY / ACCESSWIRE / January 26, 2018 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Syneos Health, Inc. (formerly INC Research Holdings, Inc. (NASDAQ: INCR)) securities between May 10, 2017 and November 9, 2017.

Click here to learn about the case: There is no cost or obligation to you.

According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) the merger with inVentiv Health, Inc. ("inVentiv") was not providing the benefit that defendants stated it would; (2) inVentiv was underperforming; (3) in turn, INCR's 2017 financial performance would be negatively impacted; and (4) as a result, defendants' statements about INCR's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

If you suffered a loss in INCR, you have until January 30, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email, by telephone at 212.425.1140, or visit

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.


Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880

SOURCE: The Law Offices of Vincent Wong

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.